Natalie Walsh

Natalie Walsh is an experienced professional in the pharmaceutical and analytical fields, currently serving as the Analytical Team Lead at Cook Medical since September 2025. Previously, Natalie held various leadership roles, including Interim Quality Excellence Manager and Stability Team Lead at Allergy Therapeutics, where responsibilities encompassed team management and operational excellence. Notable past positions include Release and Stability Team Lead at EirGen Pharma, Senior Scientist at Vistakon Pharmaceuticals, and Analytical Scientist at Indivior, with a strong focus on method development and validation across multiple laboratories. Natalie's educational background includes a Bachelor of Science in Pharmaceutical and Forensics Analysis and a Lean Six Sigma Green Belt certification. Membership in the Royal Society of Chemistry since 2014 further underscores commitment to the field.